Mamdani

This style of fuzzy conditional statement is often called a Mamdani -type rule, after Mamdani (1976) who first used it in a fuzzy rulebase to control steam plant. 

Returning to the main menu and double-elieking on the eentre box entitled Pendulum IF (mamdani) will bring up the FIS rule editor, as shown in Figure A1.7. Highlighted are the anteeedents and the eonsequent of Rule 1. 

Name =Pendulumll Type =mamdani Numlnputs=4 InLabels= theta tdot... 

Juurlink DN, Mamdani MM, Kopp A, et al. Drug-induced lithium toxicity in the elderly a population-based study 1 Am Geriatr Soc 2004 52 794-798. 

Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003 289(13) 1652-1658. 

Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med 2002 17(9) 717-20. 

Shulman KI, Sykora K, Gill Ss, Mamdani M, Anderson G, Marras C, Wodchis WP, Lee PE, Rochon P. New thyroxine treatment in older adults beginning lithium therapy implications for clinical practice. Am J Geriatr Psychiatry 2005 13 299-304. 

A. P. Siskos, A. Baerga-Ortiz, S. Bali, V. Stein, H. Mamdani, D. Spiteller,... 

Kurdyak PA, Juurlink DN, Kopp A, Hermann N, Mamdani MM. Antidepressants, warfarin and risk of hemorrhage. J Clin Psychopharmacol 2005 25 561 1. 

Shulman KI, Sykora K, Gill SS, Mamdani M, Bronskill S, Wodchis WP, Anderson G, Rochon P. Incidence of delirium in older adults newly prescribed lithium or valproate a population-based cohort study. J Clin Psychiatry 2005 66 424-7. 

Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Atypical antipsycho-tics and parkinsonism. Arch Intern Med 2005 165 1882-8. 

Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004 161 1113-5. 

Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SLT, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. Atypical antipsychotic drugs and risk of ischaemic stroke population based retrospective cohort study. BMJ 2005 330 445. 

Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MBVeterans Affairs Status Epilepticus Cooperative Study Group. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998 339(12) 792-8. 

Mamdani MM, Racine E, McGreadie S, Zimmerman G, O Sullivan TL, Jensen G et al. Glinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy 1999 19 1064 1074. 

Budenholzer BR, Geis GS, Mamdani M, Jumlmk DN, Anderson GM, Stover RR, Juni P, Rutjes AW, Dieppe PA. Are selective COX 2 inhibitors superior to traditional NSAIDs BMJ 2002 325 161. 

Mamdani M, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, Austin PC, Laupacis A. Observational study of upper gastrointestinal... 

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004 351(6) 543-51. 

In a similar study, Mamdani et al. conducted a retrospective cohort study from 1998- 2001 with NSAID naive elderly patients who had either celecoxib, ro-fecoxib, naproxen, or other non-naproxen NSAIDs. [155] Prior to adjusting compared to the community group there was a significant increased risk of AMIs for all NSAIDs except naproxen which only trended towards an increase. But once the values were adjusted for comparison to their controls none of the groups had an increased risk that was significantly different than the controls. This study was designed to determine if naproxen had would decrease the risk of AMIs and they concluded that naproxen has no cardioprotective properties. This study also showed an increased risk of AMI for high dose ibuprofen. 

Mamdani etaLlU3] 2004 Population- Primary diagnosis based ofCHF retrospective cohort 38882 individuals 66 years and older who were prescribed study and 100000 randomly selected non-NSAID users matched by sex and age % study cohort w/ admission procedures for CHF in past 5 years Non-NSAID 4% (4475/100000). Celexocib 6% (1170/18908) Rofecoxib 6% (857/14583). Non-selective NSAIDS 5% (542/11606) Adjusted Rate Ratio Rofecoxib relative to celecoxib for admission for CHF 1.8 (1.4-2.4) Non-selective NSAIDs relative to celecoxib for admission for CHF 1.4 (1.0-1.9) and (rofecoxib users relative to non-NSAID users. Additional analysis with age-matched and sex-matched controls showed similar patterns. Increased risk of CHF in elderly patients when using rofecoxib and non-selective NSAIDs (but not celecoxib)... 

Mamdani M, Rochon P, Juurlink DN et al. Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Archives of Internal Medicine 2003,163 481 -486. 

Mamdani M, JuurlinkDN, Lee DSetal. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients a population-based cohort study. Lancet 2004 363 1751-1756. 

---